Compounds > penicillanic acid
Page last updated: 2024-08-17

penicillanic acid and Cystic Fibrosis

penicillanic acid has been researched along with Cystic Fibrosis in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19902 (10.00)18.7374
1990's1 (5.00)18.2507
2000's1 (5.00)29.6817
2010's15 (75.00)24.3611
2020's1 (5.00)2.80

Authors

AuthorsStudies
Engdahl, S; Pettit, RS; Riggsbee, D1
LeCleir, LK; Pettit, RS1
Blasi, F; Downey, DG; Elborn, JS; Gramegna, A; Millar, BC; Moore, JE1
Finklea, JD; Hollaway, R; Jain, R; Le, J; Lee, F; Lowe, K1
Beegle, S; Butterfield, JM; Farkas, J; Lodise, TP; Pai, MP; Rosen, J1
Aghazadeh, M; Hojabri, T; Hojabri, Z; Mahdian, R; Nahaei, MR; Pajand, O; Pirzadeh, T; Rahmati, M1
Diab Cáceres, L; Girón Moreno, RM; Marcos, MC1
Adelfred, A; Brock, B; Hardlei, TF; Jensen-Fangel, S; Kragh Thomsen, M; Nejatbakhsh, Y; Öbrink-Hansen, K; Petersen, E1
McClain, D; Vickery, SB; Wargo, KA1
Cies, JJ; Kuti, JL; Monogue, ML; Muhlebach, M; Nicolau, DP; Pettit, RS1
Abdel-Haq, N; Ang, JY; Nicolau, DP; Satlin, MJ; Thabit, AK; van Duin, D; Zhu, F1
Mayer, B; Meinus, C; Roehmel, JF; Schwarz, C1
Brockhurst, MA; Davies, EV; James, CE; Winstanley, C1
Compain, F; Grohs, P; Kaibi, I; Lavollay, M; Mainardi, JL; Morand, P; Podglajen, I; Taieb, G1
Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT1
Marik, PE; Parekh, P1
Jones, RN; Mutnick, AH; Turner, PJ1
Babin, S; Blessing-Moore, J; Hsu, YP; Lewiston, NJ; Moss, RB1
Giwercman, B; Høiby, N; Lambert, PA; Rosdahl, VT; Shand, GH1
Christiansen, L; Høiby, N; Koch, C; Pedersen, SS; Pressler, T; Szaff, M1

Reviews

1 review(s) available for penicillanic acid and Cystic Fibrosis

ArticleYear
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.
    Pediatric pulmonology, 2013, Volume: 48, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefepime; Ceftazidime; Cephalosporins; Clavulanic Acids; Cystic Fibrosis; Disease Progression; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin

2013

Trials

2 trial(s) available for penicillanic acid and Cystic Fibrosis

ArticleYear
Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations.
    The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Serum; Time Factors; Treatment Outcome; Young Adult

2014
Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11

    Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Patient Safety; Penicillanic Acid; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Tazobactam

2016

Other Studies

17 other study(ies) available for penicillanic acid and Cystic Fibrosis

ArticleYear
Evaluation of the safety of piperacillin-tazobactam extended infusion in pediatric cystic fibrosis patients.
    Pediatric pulmonology, 2023, Volume: 58, Issue:4

    Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Humans; Infant, Newborn; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies

2023
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
    Pediatric pulmonology, 2017, Volume: 52, Issue:8

    Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin

2017
In vitro antimicrobial activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and other non-fermenting Gram-negative bacteria in adults with cystic fibrosis.
    Journal of global antimicrobial resistance, 2018, Volume: 14

    Topics: Achromobacter denitrificans; Adult; beta-Lactamase Inhibitors; Burkholderia cenocepacia; Cephalosporins; Colistin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Sputum; Stenotrophomonas maltophilia; Tazobactam

2018
Ceftolozane/tazobactam sensitivity patterns in Pseudomonas aeruginosa isolates recovered from sputum of cystic fibrosis patients.
    Diagnostic microbiology and infectious disease, 2018, Volume: 92, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tazobactam

2018
Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2014, Volume: 24

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Burns; Cephalosporinase; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2014
Cystic Fibrosis and Piperacillin-tazobactam: Adverse Reactions.
    Archivos de bronconeumologia, 2015, Volume: 51, Issue:12

    Topics: Anti-Bacterial Agents; Cystic Fibrosis; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult

2015
Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations.
    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2016, Volume: 15, Issue:2

    Topics: Anti-Bacterial Agents; Cystic Fibrosis; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2016
Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.
    Pharmacotherapy, 2016, Volume: 36, Issue:10

    Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome

2016
Multidrug-Resistant Pseudomonas aeruginosa Infection in a Child with Cystic Fibrosis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cystic Fibrosis; Drug Hypersensitivity; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam

2016
Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis.
    BMJ case reports, 2016, Oct-24, Volume: 2016

    Topics: Adult; Anemia, Hemolytic; Anti-Bacterial Agents; Cystic Fibrosis; Female; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2016
Evolutionary diversification of Pseudomonas aeruginosa in an artificial sputum model.
    BMC microbiology, 2017, 01-05, Volume: 17, Issue:1

    Topics: Bacteriophages; beta-Lactamases; Biodiversity; Biofilms; Biological Evolution; Culture Media; Cystic Fibrosis; Drug Resistance, Microbial; Penicillanic Acid; Phenotype; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tazobactam

2017
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4

    Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Tazobactam; Thienamycins

2017
Life-threatening piperacillin-induced immune haemolysis in a patient with cystic fibrosis.
    BMJ case reports, 2013, Jan-04, Volume: 2013

    Topics: Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Young Adult

2013
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
    Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:3

    Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins

2002
Allergy to semisynthetic penicillins in cystic fibrosis.
    The Journal of pediatrics, 1984, Volume: 104, Issue:3

    Topics: Adolescent; Adult; Benzeneacetamides; Carbenicillin; Child; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Intradermal Tests; Male; Penicillanic Acid; Penicillin G; Penicillins; Piperacillin; Polylysine; Pseudomonas Infections; Radioallergosorbent Test; Ticarcillin

1984
Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26, Issue:2

    Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Child; Cystic Fibrosis; Drug Resistance, Microbial; Female; Humans; Male; Penicillanic Acid; Pseudomonas aeruginosa; Sputum; Tazobactam

1990
Sultamicillin--a new antibiotic in the treatment of persistent lower respiratory tract infections caused by Haemophilus influenzae.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17, Issue:4

    Topics: Adolescent; Ampicillin; Child; Child, Preschool; Cystic Fibrosis; Diarrhea; Drug Combinations; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Lung Diseases, Obstructive; Male; Penicillanic Acid; Pneumonia; Sulbactam

1986